A Brazilian Real-Life Experience of Multiple Myeloma Patients: Final Results from the Mmybrave Multi-Center Study

被引:1
|
作者
Hungria, Vania T. M. [1 ]
Bittencourt, Rosane [2 ]
Martinez, Gracia [3 ]
Santos, Juliana De Andrade [4 ]
de Almeida, Denise Ramos [5 ]
De Piratininga Figueiredo, Vera Lucia [6 ]
Cordeiro De Farias, Danielle Leao [7 ]
Zanella, Karla Richter [8 ]
Muniz, Larissa Barchi [9 ]
Carvalho, Pedro [10 ]
Senra, Juliana [10 ]
Abreu, Rodrigo Martins [10 ]
Mattos, Ederson Roberto [11 ]
机构
[1] Clin Sao Germano, Sao Paulo, Brazil
[2] Univ Fed Rio Grande do Sul, Hematol Div, Hosp Clin Porto Alegre HCPA, Porto Alegre, RS, Brazil
[3] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, Brazil
[4] CEHON Ctr Hematol & Oncol, Salvador, BA, Brazil
[5] Hosp Sao Vicente de Paulo, Passo Fundo, RS, Brazil
[6] Hosp Servidor Publ Sao Paulo, Sao Paulo, Brazil
[7] Univ Fed Goias, Hosp Clin, Goiania, Go, Brazil
[8] CEPON Ctr Pesquisas Oncol, Florianopolis, SC, Brazil
[9] Casa Saude Santa Marcelina, Sao Paulo, Brazil
[10] Takeda Pharmaceut Brazil, Med Affairs, Sao Paulo, Brazil
[11] Fundacao Dr Amaral Carvalho, Ctr Ensino & Pesquisas, Jau, Brazil
关键词
D O I
10.1182/blood-2022-166762
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4352 / 4353
页数:2
相关论文
共 50 条
  • [1] "Real-Life" Data of Zanubrutinib in Patients with Waldenstrom Macroglobulinemia - a Multi-Center Retrospective Study
    Itchaki, Gilad
    Benjamini, Ohad
    Levi, Mor
    Nemets, Anatoly
    Yeganeh, Shay
    Assaly, Mahdi
    Gourevitch, Anna
    Saban, Revital
    Gatt, Moshe E.
    Raanani, Pia
    Vaxman, Iuliana
    BLOOD, 2022, 140 : 11981 - 11982
  • [2] REAL-LIFE EXPERIENCE WITH POMALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Cubillas, Garcia de la Torre Damian
    Inigo, Rodriguez Belen
    Alfayate, Lobo Ana
    Menendez, Cuevas Marina
    Bolanos, Calderon Estefania
    Medina, Salazar Sissy Fiorella
    Mateo, Morales Marta
    Pena, Cortijo Ascension
    Perez, Lopez Cristina
    Polo, Zarzuela Marta
    Calo, Perez Aida
    Colas, Lahuerta Blanca
    Gomez, Alvarez Miguel
    Escribano, Serrat Silvia
    Estival, Monteliu Pablo
    Gulino, Horacio
    Daorta, Melisa
    Moreno, Paredes Nahir Daniela
    Benavente, Cuesta Celina
    HAEMATOLOGICA, 2020, 105 : 151 - 151
  • [3] Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study
    Caldarola, Giacomo
    Chiricozzi, A.
    Megna, M.
    Dapavo, P.
    Giunta, A.
    Burlando, M.
    Malagoli, P.
    Dini, V
    Mariani, M.
    Fabbrocini, G.
    Quaglino, P.
    Bianchi, L.
    Parodi, A.
    Peris, K.
    De Simone, C.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (04) : 365 - 370
  • [4] A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience
    Cekdemir, Demet
    Guvenc, Serkan
    Ozdemirkiran, Fusun
    Eser, Ali
    Topts, Tayfur
    Ozkocaman, Vildan
    Sahin, Handan Haydaroglu
    Turak, Esra Ermis
    Esen, Ramazan
    Comert, Melda
    Sadrilo, Sevil
    Aslaner, Muzeyyen
    Ulu, Bahar Uncu
    Karakus, Abdullah
    Bapur, Derya Selim
    Alacacioglu, Inci
    Aydin, Demet
    Tekinalp, Atakan
    Namdaroglu, Sinem
    Ceran, Funda
    Tarkun, Pinar
    Kiper, Demet
    Cetiner, Mustafa
    Yenerel, Mustafa
    Demir, Ahmet Muzaffer
    Yilmaz, Guven
    Terzi, Hatice
    Atilla, Erden
    Malkan, Umit Yavuz
    Acar, Kadir
    Ozturk, Erman
    Tombak, Anil
    Sunu, Cenk
    Salim, Ozan
    Aslan, Nevin Alayvaz
    Sayan, Ozkan
    Ozan, Ulku
    Ayer, Mesut
    Gokgoz, Zafer
    Andic, Neslihan
    Kizilkilic, Ebru
    Noyan, Figen
    Ozen, Mehmet
    Tanrikulu, Funda Pepedil
    Alanoglu, Guchan
    Ozkan, Hasan Atilla
    Aslan, Vahap
    Cetin, Guven
    Erikci, Alev Akyol
    Deveci, Burak
    TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 (04) : 230 - 237
  • [5] Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study
    Federico Diotallevi
    Maria Esposito
    Maria Concetta Fargnoli
    Pietro Quaglino
    Luca Mastorino
    Luca Stingeni
    Katharina Hansel
    Claudio Feliciani
    Matteo Megna
    Lucia Gallo
    Agostina Legori
    Giuseppe Argenziano
    Anna Balato
    Federico Bardazzi
    Martina Burlando
    Emanuele Cozzani
    Luca Bianchi
    Marco Galluzzo
    Paolo Gisondi
    Francesco Bellinato
    Tommaso Bianchelli
    Giovanni Marco D’Agostino
    Giulia Matacchione
    Anna Campanati
    Dermatology and Therapy, 2025, 15 (2) : 323 - 336
  • [6] REAL-LIFE STUDY OF EFFICACY AND RESPONSE TO FIRST LINE TREATMENT IN PATIENTS WITH MULTIPLE MYELOMA CANDIDATES FOR TRANSPLANTATION. EXPERIENCE OF A CENTER
    Suarez Cabrera, A.
    Luzardo Henriquez, H.
    Gonzalvez, J.
    Perez, L.
    Guerra, L.
    Perera, M.
    Torres, M.
    Gomez Casares, M. T.
    Lemes, A.
    Gonzalez Perez, E.
    Saez Perdomo, M. N.
    Molero Labarta, T.
    Bravo de Laguna, Jimenez S.
    HAEMATOLOGICA, 2019, 104 : 20 - 20
  • [7] Multi-center real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland
    Mangana, J.
    Amann, V. C.
    Goldinger, S. M.
    Kaufmann, C.
    Frauchiger, A. L.
    Cheng, P.
    Stoegner, V.
    Held, U.
    Von Moos, R.
    Romano, E.
    Michielin, O.
    Braun, R.
    Levesque, M. P.
    Dummer, R.
    MELANOMA RESEARCH, 2016, 26 : E41 - E42
  • [8] Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience
    Ferhanoglu, A. Burhan
    Ozbalak, Murat
    Salihoglu, Ayse
    Soysal, Teoman
    Karadogan, Ihsan
    Paydas, Semra
    Ozdemir, Evren
    Yildiz, Birol
    Karadurmus, Nuri
    Kaynar, Leylagul
    Yegin, Zeynep Arzu
    Ozbalak, Ezgi Pinar
    Sucak, Gulsan
    Ozkocaman, Vildan
    Topcuoglu, Pervin
    Ozcan, Muhit
    Birtas, Elif
    Goker, Hakan
    BLOOD, 2017, 130
  • [9] Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience
    Murat Özbalak
    Ayşe Salihoğlu
    Teoman Soysal
    İhsan Karadoğan
    Semra Paydaş
    Evren Özdemir
    Birol Yıldız
    Nuri Karadurmuş
    Leylagül Kaynar
    Münci Yagci
    Vildan Özkocaman
    Pervin Topçuoğlu
    Muhit Özcan
    Elif Birtaş
    Hakan Göker
    Burhan Ferhanoglu
    Annals of Hematology, 2020, 99 : 301 - 307
  • [10] Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience
    Ozbalak, Murat
    Salihoglu, Ayse
    Soysal, Teoman
    Karadogan, Ihsan
    Paydas, Semra
    Ozdemir, Evren
    Yildiz, Birol
    Karadurmus, Nuri
    Kaynar, Leylagul
    Yagci, Munci
    Ozkocaman, Vildan
    Topcuoglu, Pervin
    Ozcan, Muhit
    Birtas, Elif
    Goker, Hakan
    Ferhanoglu, Burhan
    ANNALS OF HEMATOLOGY, 2020, 99 (02) : 301 - 307